Huang T, Luo Y, Wu Y, Niu L, Xiao Y, Wu T
Sci Prog. 2025; 108(1):368504251325334.
PMID: 40033936
PMC: 11877486.
DOI: 10.1177/00368504251325334.
Li G, Yu Y, Lin C, Zheng S, Tu H, Xu W
EClinicalMedicine. 2024; 79:102982.
PMID: 39720611
PMC: 11665660.
DOI: 10.1016/j.eclinm.2024.102982.
Fino N, Inker L, Greene T, Adingwupu O, Coresh J, Seegmiller J
PLoS One. 2024; 19(12):e0313154.
PMID: 39621675
PMC: 11611103.
DOI: 10.1371/journal.pone.0313154.
Ashouri R, Lertkitcharoenpon A, Maidaa M, Brunner B, Velazquez O, Lipshultz L
Am J Mens Health. 2024; 18(5):15579883241286654.
PMID: 39402920
PMC: 11483778.
DOI: 10.1177/15579883241286654.
Chen L, Jiang Y, Cheng X
Cardiovasc Toxicol. 2024; 24(10):1047-1052.
PMID: 39095622
DOI: 10.1007/s12012-024-09902-0.
Preoperative inflammatory biomarkers reveal renal involvement in postsurgical mortality in hip fracture patients: an exploratory study.
Valdes A, Ikram A, Taylor L, Zheng A, Kouraki A, Kelly A
Front Immunol. 2024; 15:1372079.
PMID: 38919625
PMC: 11197399.
DOI: 10.3389/fimmu.2024.1372079.
A lower eGFR/eGFR ratio is associated with greater cardiovascular risk (higher Framingham Risk Score) in Chinese patients with newly diagnosed type 2 diabetes mellitus.
Yang Y, Yang B, Zhao S, Liu S, Zhou H, Xu N
Ren Fail. 2024; 46(2):2346267.
PMID: 38905298
PMC: 11195453.
DOI: 10.1080/0886022X.2024.2346267.
Drug stewardship in chronic kidney disease to achieve effective and safe medication use.
Hall R, Kazancioglu R, Thanachayanont T, Wong G, Sabanayagam D, Battistella M
Nat Rev Nephrol. 2024; 20(6):386-401.
PMID: 38491222
DOI: 10.1038/s41581-024-00823-3.
Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.
Hu X, Yang X, Lu J, Li G, Dai J, Wang J
World J Gastrointest Surg. 2024; 16(2):481-490.
PMID: 38463353
PMC: 10921209.
DOI: 10.4240/wjgs.v16.i2.481.
Aerobic exercise attenuates high-fat diet-induced renal injury through kidney metabolite modulation in mice.
Xiong Y, Luan Y, Yuan L, Hong W, Wang B, Zhao H
Ren Fail. 2024; 46(1):2286330.
PMID: 38390733
PMC: 10896126.
DOI: 10.1080/0886022X.2023.2286330.
Role of cystatin C levels as an inflammatory marker in predicting endometriosis.
Kilickiran H, Halilzade I, Halilzade M, Topcuoglu C, Cinar M
Rev Assoc Med Bras (1992). 2023; 69(12):e20230613.
PMID: 38055453
PMC: 10691366.
DOI: 10.1590/1806-9282.20230613.
Cystatin C as a GFR Estimation Marker in Acute and Chronic Illness: A Systematic Review.
Adingwupu O, Barbosa E, Palevsky P, Vassalotti J, Levey A, Inker L
Kidney Med. 2023; 5(12):100727.
PMID: 37928862
PMC: 10623366.
DOI: 10.1016/j.xkme.2023.100727.
A magnetic solid phase chemiluminescent immunoassay for quantification of Cystatin C in human serum.
He J, Liang P, Wang T, Han S
BMC Biotechnol. 2023; 23(1):45.
PMID: 37821832
PMC: 10568915.
DOI: 10.1186/s12896-023-00813-6.
Discordance Between Creatinine-Based and Cystatin C-Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR.
Wang Y, Adingwupu O, Shlipak M, Doria A, Estrella M, Froissart M
Kidney Med. 2023; 5(10):100710.
PMID: 37753251
PMC: 10518599.
DOI: 10.1016/j.xkme.2023.100710.
Discrepancies between Cystatin C-Based and Creatinine-Based eGFR.
Farrington D, Surapaneni A, Matsushita K, Seegmiller J, Coresh J, Grams M
Clin J Am Soc Nephrol. 2023; 18(9):1143-1152.
PMID: 37339177
PMC: 10564370.
DOI: 10.2215/CJN.0000000000000217.
Error in Table.
JAMA. 2022; 328(22):2274.
PMID: 36511940
PMC: 9856410.
DOI: 10.1001/jama.2022.21078.
